CIK 0001771910 · Non-accelerated filer<br>Smaller reporting company
ADC Therapeutics SA
Sign in to watch- Ticker
- ADCT
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- Phone
- 41 21 653 02 00
- Business address
- BIOPOLE, ROUTE DE LA CORNICHE 3B, EPALINGES, Switzerland, 1066
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- S-4 Deal Registration Statement - Business Combination
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Results of operations · Unregistered share sale
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Grant or award Chief Medical Officer acquired 213,900 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 221,100 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 203,700 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 675,000 shares (grant or award)
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure · Other events
- 4 Shares withheld for taxes Director gave up 12,600 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 15,196 shares (to pay taxes)
Page 1 of 23 · 441 filings